Diabetes Flashcards
Pathophysiology of T1DM
Type 1 diabetes is caused by the autoimmune destruction of the insulin- producing b-cells of the islets of Langerhans. Genetic and environmental factors are thought to play a part in the onset of the disease, which usually occurs in childhood and young adulthood.
Pathophysiology of T2DM
type 2 diabetes mellitus is characterized by peripheral insulin resistance, impaired regulation of hepatic glucose production, and declining β-cell function, eventually leading toβ -cell failure
Clinical presentation of T1DM
- Feeling more thirsty than usual
- Urinating a lot
- Losing weight without trying
- Blurry vision
- Ketosis
- Polyuria
- Polydipsia
Clinical presentation of T2DM
- Feeling more thirsty than usual
- Urinating a lot
- Losing weight without trying
- Fatigue
- Slow healing of wounds
- Frequent infections
Tests used for diagnosis of diabetes
BGLs
Oral glucose tolerance test (OGTT)
Glycosylated haemoglobin (HbA1c)
Long term complications of diabetes
- Glaucoma
- Cataracts
- gastroparesis
- Peripheral neuropathy
- Coronary artery disease
- Sexual dysfunction
Risk factors for T2DM
- Have prediabetes.
- Are overweight.
- Are 45 years or older.
- Have a parent, brother, or sister with type 2 diabetes.
- Are physically active less than 3 times a week.
- Have ever had gestational diabetes (diabetes during pregnancy) or given birth to a baby who weighed over 9 pounds.
Rationale for drug use Diabetes
Symptom relief (eg polyuria, polydipsia).
Control of blood glucose concentration.
Prevention or delay of long-term microvascular complications (eg nephropathy, neuropathy, retinopathy) and macrovascular events.
Management of T1DM
Basal bolus
Split mix
Pros and cons of basal bolus VS split mix
Split-Mixed Regime: 2 daily injections of a premixed insulin eg NovoMix 30 (30% short acting, 70% intermediate acting). Simple, convenient, lower risk of hypos, less flexible, can’t skip meals.
Basal-bolus Regime: 3 short acting (before meals), 1 long acting (eg Lantus) injections daily. Flexible, better BSL control, regular BSL monitoring needed, doesn’t cover snacks, risk of hypos.
Short acting VS long acting insulin
Short/rapid Acting: better control, more flexible but also more injections & more risk of hypos.
Long acting: fewer injections, less risk of hypos but also less flexible & looser control
Goals of T2DM management
- Relieve symptoms of hyperglycaemia (eg polyuria, polydipsia, as well as more subtle changes related to general wellbeing)
- Avoid acute complications of hyperglycaemia, such as diabetic ketoacidosis
- Avoid hypoglycaemia
- Reduce chronic complications.
Management strategies for T2DM
- Individualised treatment targets
- A healthy eating plan
- An exercise plan
- Ways to reduce cardiovascular risk, in particular smoking cessation, blood pressure control and dyslipidaemia management
- SNAP: quit Smoking, improve Nutrition (lose weight if needed), moderate Alcohol, increase Physical activity.
- Using noninsulin anti-hyperglycaemic drugs, if required
- Using insulin, if required
- Education in self-monitoring, adjusting treatment and how to cope with illness that affects the patient’s blood glucose concentration
- Screening for, and treating, complications of diabetes (see Diabetes: complications)
Steps for T2DM if exercise and diet alone don’t work
- Add Metformin
- Add an additional drug: either DPP-4 inhibitor or GLP-1 agonist
- Add a sulfonylurea. If this fails add a DPP-4 inhibitor OR GLP-1 agonist OR acarbose OR thiazolidinediones
- Add insulin
Alt: continue metformin and add a basal bolus
Drugs for Diabetes management
Both T1DM and T2DM
Insulin
Biguanides
T2DM only
Alpha-glucosidase inhibitors
Meglitinides
SGLT2 Inhibitors
DPP-4 Inhibitors
GLP-1 Agonists
Sulfonylureas
Thiazolidinediones
Indication
GLP-1 agonists
T2DM
MOA
GLP-1 agonists
Incretin therapies are utilised to help balance insulin levels in hormones in the GI tract.
Stimulating glucose-dependent insulin release from the pancreatic islets
Adverse effects
GLP-1 agonists
- Nausea
- Injection site reactions
- Headache
- Nasopharyngitis
Drug interactions
GLP-1 agonists
Other drugs that could lead to hypoglycaemia:
* insulins
* Sulfonylureas
Advantages
GLP-1 agonists
- No hypos
- Reduced CVD
- Improved NAFLD
- Once a week therapy possible
Disadvantages
GLP-1 agonists
- Requires injection
- Pancreatitis
- Thyroid cancer
- Gall bladder disease
Suffix
GLP-1 agonists
“glutide”
Drug class that ends in
“glutide”
GLP-1 agonists
Indication
Sulfonylureas
T2DM
MOA
Sulfonylureas
Increase pancreatic insulin secretion; may decrease insulin resistance.
Contraindications
Sulfonylureas
Ketoacidosis
T1DM
Adverse effects
Sulonylureas
Hypoglycaemia
Weight gain
Practice points
Sulfonylureas
- With food to decreased risk of hypoglycaemia
- Controlled release tablet – DO NOT CRUSH
- Avoid binge drinking, eat when drinking alcohol
Advantages
Sulfonylureas
- Relatively inexpensive
- Multiple formulations
- Minimal side effects
Disadvantages
Sulfonylureas
Progression of T2DM and increased insulin resistance
(secondary failure)